The time to trade-off method versus the EQ-5D index to determine health utility in patients with rheumatoid arthritis

The time to trade-off method versus the EQ-5D index to determine health utility in patients with rheumatoid arthritis

Clinicoeconomic studies require that the health utility index be used to calculate quality-adjusted life years (QALY). Choice of an adequate method for determining health utility for patients with rheumatoid arthritis (RA) makes it necessary to compare various approaches to this assessment. Objectiv...

Full description

Bibliographic Details
Main Authors:	Dmitriy Vladimirovich Goryachev, Sh F Erdes, Dmitry Vladimirovich Goryachev
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2010-12-01
Series:	Научно-практическая ревматология
Subjects:	eq-5d rheumatoid arthritis utility index time to trade-off method (tto)
Online Access:	https://rsp.mediar-press.net/rsp/article/view/962

Similar Items

Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan
by: Hsin-Yi Lee, et al.
Published: (2013-11-01)

Feasibility, acceptability and construct validity of EQ-5D in systemic sclerosis
by: Roberta Gualtierotti, et al.
Published: (2016-12-01)

Quality of life in patients with rheumatoid arthritis during rituximab therapy
by: Tatiana Alekseyevna Raskina, et al.
Published: (2013-06-01)

Similar responses to EQ-5D-3L by two elicitation methods: visual analogue scale and time trade-off
by: Xiuying Wang, et al.
Published: (2020-05-01)

Preparatory study for the revaluation of the EQ-5D tariff: methodology report
by: Brendan Mulhern, et al.
Published: (2014-02-01)

Mapping health assessment questionnaire disability index onto EQ-5D-5L in China
by: Chuchuan Wan, et al.
Published: (2023-04-01)

Estimating health state utilities in Duchenne muscular dystrophy using the health utilities index and EQ-5D-5L
by: Ivana F. Audhya, et al.
Published: (2023-12-01)

Pengukuran Kualitas Hidup Pasien Kanker Payudara di Kota Denpasar Menggunakan Instrumen EQ-5D-5L
by: Abdillah Mursyid, et al.
Published: (2019-09-01)

Quality of Life and Cost Study of Rheumatoid Arthritis Therapy With Biological Medicines
by: Vladimira V. Boyadzieva, et al.
Published: (2018-07-01)

Psychometric properties of the EQ-5D-5L compared with EQ-5D-3L in cancer patients in Iran
by: Nasrin Moradi, et al.
Published: (2022-12-01)

Health status based on EQ-5D-5L for the cancer patient population in Malaysia
by: Sharifa Ezat Wan Puteh, et al.
Published: (2024-04-01)

A pilot study of subjective well-being in colorectal cancer patients and their caregivers
by: Graham J, et al.
Published: (2017-10-01)

A Comparison of EQ-5D-3L, EQ-5D-5L, and SF-6D Utilities of Patients with Musculoskeletal Disorders of Different Severity: A Health-Related Quality of Life Approach
by: Nikolaos Kontodimopoulos, et al.
Published: (2022-07-01)

Population norms for the EQ-5D-3L and EQ-5D-5L in Romania
by: Elena Olariu, et al.
Published: (2023-07-01)

Health-related quality of life in primary care patients: a comparison between EQ-5D-5L utility score and EQ-visual analogue scale
by: Richard Huan Xu, et al.
Published: (2024-01-01)

Direct healthcare resource utilisation, health-related quality of life, and work productivity in patients with moderate rheumatoid arthritis: an observational study
by: James Galloway, et al.
Published: (2021-03-01)

EQ-5D: a plea for accurate nomenclature
by: Richard Brooks, et al.
Published: (2020-07-01)

Comparison of the EQ-5D-Y-5L, EQ-5D-Y-3L and PedsQL in children and adolescents
by: Janine Verstraete, et al.
Published: (2022-06-01)

EQ-5D self-reported health in Barbados and Jamaica with EQ-5D-5L population norms for the English-speaking Caribbean
by: Henry Bailey, et al.
Published: (2021-03-01)

In search of a ‘pan-European value set’; application for EQ-5D-3L
by: Ayesha Sajjad, et al.
Published: (2023-01-01)

Health utility scores of family caregivers for leukemia patients measured by EQ-5D-3L: a cross-sectional survey in China
by: Hongjuan Yu, et al.
Published: (2018-10-01)

Health-related quality of life in patients with rheumatoid arthritis
by: Wanruchada Katchamart, et al.
Published: (2019-08-01)

Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis
by: Andrews K. Tawiah, et al.
Published: (2019-04-01)

Measurement of Health-Related Quality of Life Among Colorectal Cancer Patients Using the Vietnamese Value Set of the EQ-5D-5L
by: Tran BT, et al.
Published: (2020-12-01)

Concordance among Swedish, German, Danish, and UK EQ-5D-3L Value Sets: Analyses of Patient-Reported Outcomes in the Swedish Hip Arthroplasty Register
by: Fitsum Sebsibe Teni, et al.
Published: (2021-09-01)

EQ-5D™-derived utility values for different levels of migraine severity from a UK sample of migraineurs
by: Stafford Megan R, et al.
Published: (2012-06-01)

Valuing EQ-5D-Y: the current state of play
by: N. Devlin, et al.
Published: (2022-07-01)

Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi
by: Lucky G. Ngwira, et al.
Published: (2023-03-01)

Comparing measurement properties of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients
by: Titi Sahidah Fitriana, et al.
Published: (2021-11-01)

Does the child’s health influence the caregiver’s health using the EQ-5D instruments?
by: Janine Verstraete, et al.
Published: (2020-02-01)

Estimating the severity distribution of disease in South Korea using EQ-5D-3L: a cross-sectional study
by: Minsu Ock, et al.
Published: (2016-03-01)

The validity of the Shona version of the EQ-5D, of life measure
by: J. M. Jelsma
Published: (2002-01-01)

VALIDATION OF THE EQ-5D-5L VERSION IN RUSSIA
by: A. I Akulova, et al.
Published: (2018-07-01)

EQ-5D-Y-3L and EQ-5D-Y-5L proxy report: psychometric performance and agreement with self-report
by: Titi Sahidah Fitriana, et al.
Published: (2022-06-01)

Perbandingan EQ-5D-5L dan SF-6D Untuk Mengukur Index Utility Kesehatan Pada Populasi Umum di Yogyakarta
by: Tri Murti Andayani, et al.
Published: (2020-03-01)

Health-Related Quality of Life in Patients With Different Diseases Measured With the EQ-5D-5L: A Systematic Review
by: Ting Zhou, et al.
Published: (2021-06-01)

Pharmacoeconomic analysis of the use of tocilizumab in therapy for rheumatoid arthritis:imitation simulation
by: Dmitry Vladimirovich Goryachev, et al.
Published: (2010-04-01)

EQ-5D-5L Slovenian population norms
by: Valentina Prevolnik Rupel, et al.
Published: (2020-10-01)

Mapping analysis to estimate EQ-5D utility values using the COPD assessment test in Korea
by: Jaeok Lim, et al.
Published: (2019-06-01)

Health-related quality of life measured using the EQ-5D–5 L: population norms for the capital of Iran
by: Zahra Emrani, et al.
Published: (2020-04-01)